Narcolepsy without unique MHC class II antigen association: studies in the canine model.
Human narcolepsy is almost exclusively associated with the major histocompatibility complex (MHC) class II antigen HLA-DR2 and is the strongest HLA-disease association described to date. Canine narcolepsy resembles the human disease in its behavioral manifestations and responses to therapeutic drugs. Therefore, mixed leukocyte culture (MLC) was used to study differences in the canine MHC class II (DLA-D) antigens present in narcoleptic dogs to determine whether an analogous, unique DLA-D antigen could be identified in canine narcolepsy. Results show at least five different DLA-D antigens appear in potential narcoleptic haplotypes among the 29 dogs studied. The data demonstrate that, unlike man, in dogs there is no unique D locus antigen associated with narcolepsy and further suggest that linkage disequilibrium with a specific MHC antigen is unlikely to be essential for the manifestation of canine narcolepsy. Because human narcolepsy is thought to be multigenic, the canine narcolepsy-MHC dissociation suggests that the dog model may help elucidate the non-MHC narcolepsy gene(s).
Dean
R R
RR
Department of Psychiatry, Stanford University School of Medicine, California.
Kilduff
T S
TS
Dement
W C
WC
Grumet
F C
FC
D000818:Animals; D004195:Disease Models, Animal; D004283:Dog Diseases / Q000235:genetics*; D004285:Dogs; D000949:Histocompatibility Antigens Class II / Q000032:analysis*; D007963:Leukocytes, Mononuclear / Q000032:analysis; D007959:Lymphocyte Culture Test, Mixed; D009290:Narcolepsy / Q000235:genetics* / Q000276:immunology / Q000662:veterinary; D010375:Pedigree; D013577:Syndrome
D000949:Histocompatibility Antigens Class II